JP2002506648A5 - - Google Patents

Download PDF

Info

Publication number
JP2002506648A5
JP2002506648A5 JP2000536863A JP2000536863A JP2002506648A5 JP 2002506648 A5 JP2002506648 A5 JP 2002506648A5 JP 2000536863 A JP2000536863 A JP 2000536863A JP 2000536863 A JP2000536863 A JP 2000536863A JP 2002506648 A5 JP2002506648 A5 JP 2002506648A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
subject
composition according
vaccination
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000536863A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002506648A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK1999/000136 external-priority patent/WO1999047680A1/en
Publication of JP2002506648A publication Critical patent/JP2002506648A/ja
Publication of JP2002506648A5 publication Critical patent/JP2002506648A5/ja
Pending legal-status Critical Current

Links

JP2000536863A 1998-03-16 1999-03-16 突然変異体組換えアレルゲン Pending JP2002506648A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK0364/98 1998-03-16
DK36498 1998-03-16
PCT/DK1999/000136 WO1999047680A1 (en) 1998-03-16 1999-03-16 Mutant recombinant allergens

Publications (2)

Publication Number Publication Date
JP2002506648A JP2002506648A (ja) 2002-03-05
JP2002506648A5 true JP2002506648A5 (https=) 2006-05-11

Family

ID=8092687

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000536863A Pending JP2002506648A (ja) 1998-03-16 1999-03-16 突然変異体組換えアレルゲン

Country Status (19)

Country Link
US (1) US20040091500A1 (https=)
EP (1) EP1062341B1 (https=)
JP (1) JP2002506648A (https=)
KR (1) KR20010041918A (https=)
CN (1) CN1332029C (https=)
AT (1) ATE408690T1 (https=)
AU (1) AU749749B2 (https=)
CA (1) CA2323687C (https=)
DE (1) DE69939584D1 (https=)
DK (1) DK1062341T3 (https=)
ES (1) ES2313776T3 (https=)
HU (1) HUP0101464A3 (https=)
IL (2) IL138339A0 (https=)
NO (1) NO328354B1 (https=)
NZ (1) NZ506665A (https=)
PL (1) PL194804B1 (https=)
PT (1) PT1062341E (https=)
WO (1) WO1999047680A1 (https=)
ZA (1) ZA200004819B (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1280817A2 (en) * 2000-04-28 2003-02-05 Novozymes A/S Production and use of protein variants having modified immunogenecity
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.
IT1318690B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti dell'allergene maggiore par j 2 di parietaria judaica.
EP1340085B1 (en) * 2000-10-17 2008-07-30 Besst-Test Aps Assay for directly detecting a biological cell in a body fluid sample
ATE414773T1 (de) * 2000-11-16 2008-12-15 Alk Abello As Mutante allergene
DE60032250T2 (de) * 2000-12-28 2007-03-15 Biomay Produktions- Und Handels-Aktiengesellschaft Behandlung von Allergien
WO2002070665A2 (en) * 2001-03-02 2002-09-12 The Rockefeller University Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
EP1436627A2 (en) * 2001-10-05 2004-07-14 Novozymes A/S Kit for predicting binding of a specific antibody to a potential immunogen and method of screening
EP1478662B2 (de) * 2002-02-27 2017-07-05 Merck Patent GmbH Verfahren zur herstellung von hypoallergenem birkenpollenhauptallergen rbet v 1
CN1668737A (zh) * 2002-05-16 2005-09-14 阿尔克-阿贝洛有限公司 重组Bet.V.1过敏原突变体及其方法和制备
CA2503886A1 (en) * 2002-11-01 2004-05-13 Alk-Abello A/S Recombinant protein variants
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
EP1599185A1 (en) 2003-02-28 2005-11-30 Alk-Abello A/S Dosage form having a saccharide matrix
RU2006126051A (ru) 2003-12-19 2008-01-27 Альк-Абелло А/С (Dk) Способы получения партии активного фармацевтического ингредиента, контейнер, содержащий криогранулы аллергенного продукта, и криогранула аллергенного продукта
AU2006299310A1 (en) 2005-10-04 2007-04-12 Alk-Abello A/S Solid vaccine formulation
ITMI20052517A1 (it) * 2005-12-29 2007-06-30 Lofarma Spa Varianbtio ipoallergeniche dell'allergene maggiore bet v 1 di polline di betula verrucosa
WO2007123488A1 (en) * 2006-04-20 2007-11-01 National University Of Singapore Recombinant lactobacillus and use of the same
CN103736086A (zh) * 2007-02-15 2014-04-23 曼康公司 用于增强t细胞应答的方法
CA2682054A1 (en) 2007-03-28 2008-10-02 Alk-Abello A/S Use of an adjuvanted allergy vaccine formulation for parenteral administration
EP2028188A1 (en) 2007-08-21 2009-02-25 Biomay AG Hypoallergenic molecules
DE202008006598U1 (de) 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
WO2010146171A1 (en) 2009-06-19 2010-12-23 Alk-Abelló A/S Novel manner of administering allergen in allergen specific immunotherapy
CN102584966A (zh) * 2011-11-14 2012-07-18 广州医学院第二附属医院 一种重组花生过敏原与突变体及其制备方法和应用
CN102617719A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组大米过敏原与突变体及其制备方法和应用
CN102690340A (zh) * 2012-03-30 2012-09-26 广州医学院第二附属医院 一种重组巴西坚果过敏原与突变体及其制备方法和应用
CN102603879A (zh) * 2012-03-30 2012-07-25 广州医学院第二附属医院 一种重组大豆过敏原与突变体及其制备方法和应用
CN102617715A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组真菌主要过敏原与突变体及其制备方法和应用
CN102675439A (zh) * 2012-03-31 2012-09-19 广州医学院第二附属医院 一种重组黑麦草花粉过敏原与突变体的制备方法和应用
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
WO2021097174A1 (en) * 2019-11-13 2021-05-20 The Regents Of The University Of Michigan Nanoemulsion compositions for treating aeroallergen associated allergy and inflammation
CN111187606B (zh) * 2020-02-25 2022-06-14 江苏海洋大学 一种用于海水基可循环清洁压裂液的表面活性剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804201A (en) * 1996-03-11 1998-09-08 The Rockefeller University Immunomodulatory peptides of vespid antigen 5
AU743647B2 (en) * 1998-01-31 2002-01-31 Mt. Sinai School Of Medicine Of New York University Methods and reagents for decreasing allergic reactions
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.

Similar Documents

Publication Publication Date Title
JP2002506648A5 (https=)
JP2004532810A5 (https=)
JP2004529078A5 (https=)
JP2004523498A5 (https=)
JP2004525194A5 (https=)
JP2004515500A5 (https=)
CA2380072A1 (en) Nicotine in therapeutic angiogenesis and vasculogenesis
JP2003520232A5 (https=)
WO2004056337A3 (en) Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
JP2001131087A5 (https=)
WO2004058837A3 (de) Ampholytisches copolymer und dessen verwendung
JP2005526147A5 (https=)
DK1399133T4 (da) Sammensætning med langvarig frigivelse omfattende mælkesyre-glykolsyre-copolymer samt fremgangsmåde til fremstilling heraf
PL366401A1 (en) Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc.
JP2002523184A5 (https=)
ATE485833T1 (de) Pharmazeutische zusammensetzungen, die die immunogenität von schwach immunogenen antigenen fördern
JP2004534810A5 (https=)
JP2001513504A5 (https=)
JP2001524364A5 (https=)
DE60202590D1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
JP2002509169A5 (https=)
WO2002053149A3 (de) Arzneimittel enthaltend ein polyamin als wirksubstanz
JP2002114686A5 (https=)
SE0001916D0 (sv) Novel formulation
JP2000095900A5 (https=)